ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT01842451
Brief Title: A Phase 2 Study to Evaluate the Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics of VX-135 and Daclatasvir in Subjects With Genotype 1 Chronic Hepatitis C Chronic Hepatitis C

First Submitted : April 24, 2013
First Submitted that Met QC Criteria : April 24, 2013
First Posted : April 29, 2013 (Estimate)

Certification/Extension First Submitted : October 23, 2015
Certification/Extension First Submitted that Met QC Criteria : October 23, 2015
Certification/Extension First Posted : November 20, 2015 (Estimate)

Last Update Submitted that Met QC Criteria : November 30, 2015
Last Update Posted : December 29, 2015 (Estimate)